Literature DB >> 20008540

Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.

John C Phipps1, David M Aronoff, Jeffrey L Curtis, Deepti Goel, Edmund O'Brien, Peter Mancuso.   

Abstract

Cigarette smoke exposure increases the risk of pulmonary and invasive infections caused by Streptococcus pneumoniae, the most commonly isolated organism from patients with community-acquired pneumonia. Despite this association, the mechanisms by which cigarette smoke exposure diminishes host defense against S. pneumoniae infections are poorly understood. In this study, we compared the responses of BALB/c mice following an intratracheal challenge with S. pneumoniae after 5 weeks of exposure to room air or cigarette smoke in a whole-body exposure chamber in vivo and the effects of cigarette smoke on alveolar macrophage phagocytosis of S. pneumoniae in vitro. Bacterial burdens in cigarette smoke-exposed mice were increased at 24 and 48 h postinfection, and this was accompanied by a more pronounced clinical appearance of illness, hypothermia, and increased lung homogenate cytokines interleukin-1beta (IL-1beta), IL-6, IL-10, and tumor necrosis factor alpha (TNF-alpha). We also found greater numbers of neutrophils in bronchoalveolar lavage fluid recovered from cigarette smoke-exposed mice following a challenge with heat-killed S. pneumoniae. Interestingly, overnight culture of alveolar macrophages with 1% cigarette smoke extract, a level that did not affect alveolar macrophage viability, reduced complement-mediated phagocytosis of S. pneumoniae, while the ingestion of unopsonized bacteria or IgG-coated microspheres was not affected. This murine model provides robust additional support to the hypothesis that cigarette smoke exposure increases the risk of pneumococcal pneumonia and defines a novel cellular mechanism to help explain this immunosuppressive effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008540      PMCID: PMC2825918          DOI: 10.1128/IAI.00963-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Phagocytosis: elegant complexity.

Authors:  Lynda M Stuart; R Alan B Ezekowitz
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

2.  Pneumococcal vaccination in developing countries.

Authors:  Orin S Levine; Katherine L O'Brien; Maria Knoll; Richard A Adegbola; Steven Black; Thomas Cherian; Ron Dagan; David Goldblatt; Adenike Grange; Brian Greenwood; Tom Hennessy; Keith P Klugman; Shabir A Madhi; Kim Mulholland; Hanna Nohynek; Mathuram Santosham; Samir K Saha; J Anthony Scott; Samba Sow; Cynthia G Whitney; Felicity Cutts
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 4.  The role of the macrophage in lung disease mediated by bacteria.

Authors:  Helen M Marriott; David H Dockrell
Journal:  Exp Lung Res       Date:  2007-12       Impact factor: 2.459

5.  Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.

Authors:  Alison R Kerr; Gavin K Paterson; Alan Riboldi-Tunnicliffe; Tim J Mitchell
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model.

Authors:  Vatsana Phaybouth; Shan-Ze Wang; Julie A Hutt; Jacob D McDonald; Kevin S Harrod; Edward G Barrett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-08-26       Impact factor: 5.464

7.  The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles.

Authors:  Mohamed S Arredouani; Zhiping Yang; Amy Imrich; Yaoyu Ning; Guozhong Qin; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-04       Impact factor: 6.914

8.  Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia.

Authors:  A Hsu; D M Aronoff; J Phipps; D Goel; P Mancuso
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

9.  New evidence of risk factors for community-acquired pneumonia: a population-based study.

Authors:  J Almirall; I Bolíbar; M Serra-Prat; J Roig; I Hospital; E Carandell; M Agustí; P Ayuso; A Estela; A Torres
Journal:  Eur Respir J       Date:  2008-01-23       Impact factor: 16.671

10.  Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.

Authors:  Sandra Hodge; Greg Hodge; Jessica Ahern; Hubertus Jersmann; Mark Holmes; Paul N Reynolds
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-13       Impact factor: 6.914

View more
  60 in total

1.  Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Repeated Exposure to Streptococcus pneumoniae Exacerbates Chronic Obstructive Pulmonary Disease.

Authors:  Xuxu Gou; Qiao Zhang; Sunil More; Gayan Bamunuarachchi; Yurong Liang; Faizan Haider Khan; Rachel Maranville; Emily Zuniga; Changzheng Wang; Lin Liu
Journal:  Am J Pathol       Date:  2019-06-18       Impact factor: 4.307

3.  Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout mice.

Authors:  Jennifer M Dolan; Jason B Weinberg; Edmund O'Brien; Anya Abashian; Megan C Procario; David M Aronoff; Leslie J Crofford; Marc Peters-Golden; Lindsay Ward; Peter Mancuso
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-08       Impact factor: 5.464

4.  Why do we need a nonhuman primate model of smoking-induced COPD?

Authors:  Jeffrey L Curtis; Christine M Freeman
Journal:  Am J Pathol       Date:  2015-01-07       Impact factor: 4.307

5.  Reply to Eapen et al.: Dysfunctional Immunity and Microbial Adhesion Molecules in Smoking-induced Pneumonia.

Authors:  Jennifer L Larson-Casey; A Brent Carter
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 21.405

6.  Oxidized phospholipids impair pulmonary antibacterial defenses: evidence in mice exposed to cigarette smoke.

Authors:  Rajesh K Thimmulappa; Xing Gang; Jung-Hyun Kim; Thomas E Sussan; Joseph L Witztum; Shyam Biswal
Journal:  Biochem Biophys Res Commun       Date:  2012-08-22       Impact factor: 3.575

Review 7.  Indoor air pollution and respiratory health of children in the developing world.

Authors:  Sumal Nandasena; Ananda Rajitha Wickremasinghe; Nalini Sathiakumar
Journal:  World J Clin Pediatr       Date:  2013-05-08

8.  Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages.

Authors:  Richard N van Zyl-Smit; Anke Binder; Richard Meldau; Patricia L Semple; Alicia Evans; Peter Smith; Eric D Bateman; Keertan Dheda
Journal:  Thorax       Date:  2013-11-28       Impact factor: 9.139

9.  Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections.

Authors:  Tariq A Bhat; Suresh Gopi Kalathil; Paul N Bogner; Austin Miller; Paul V Lehmann; Thomas H Thatcher; Richard P Phipps; Patricia J Sime; Yasmin Thanavala
Journal:  J Immunol       Date:  2018-03-19       Impact factor: 5.422

10.  Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice.

Authors:  Jeffrey E Gotts; Lauren Chun; Jason Abbott; Xiaohui Fang; Naoki Takasaka; Stephen L Nishimura; Matthew L Springer; Suzaynn F Schick; Carolyn S Calfee; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-15       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.